UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

Neuropsychopharmacology (New York, N.Y.), 2021-02, Vol.46 (3), p.537-544

2021

Link zum Volltext

Verfügbarkeit prüfen

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects

Neuropsychopharmacology (New York, N.Y.), 2020-02, Vol.45 (3), p.462-471

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis

Scientific reports, 2021-05, Vol.11 (1), p.10851-10851, Article 10851

2021

Link zum Volltext

Verfügbarkeit prüfen

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

Neuropsychopharmacology (New York, N.Y.), 2022-05, Vol.47 (6), p.1180-1187

2022

Link zum Volltext

Verfügbarkeit prüfen

Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies

Journal of psychopharmacology (Oxford), 2021-05, Vol.35 (5), p.556-565

2021

Link zum Volltext

Verfügbarkeit prüfen

Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects

PloS one, 2018-06, Vol.13 (6), p.e0199384-e0199384

2018

Link zum Volltext

Verfügbarkeit prüfen

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens

Neuropsychopharmacology (New York, N.Y.), 2021-02, Vol.46 (3), p.545-553

2021

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Safety pharmacology of acute LSD administration in healthy subjects

Psychopharmacology, 2022-02, Vol.239 (2), p.661-661

2022

Link zum Volltext

Verfügbarkeit prüfen

No Influence of Dopamine System Gene Variations on Acute Effects of MDMA

Frontiers in psychiatry, 2019-10, Vol.10, p.755-755

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects

Frontiers in pharmacology, 2017-09, Vol.8, p.617-617

2017

Link zum Volltext

Verfügbarkeit prüfen

Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects

Frontiers in pharmacology, 2022-07, Vol.13, p.906639

2022

Link zum Volltext

Verfügbarkeit prüfen

In vitro and in vivo metabolism of psilocybin's active metabolite psilocin

Frontiers in pharmacology, 2024, Vol.15, p.1391689-1391689

2024

Link zum Volltext

Verfügbarkeit prüfen

Safety pharmacology of acute MDMA administration in healthy subjects

Journal of psychopharmacology (Oxford), 2017-05, Vol.31 (5), p.576-588

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety pharmacology of acute LSD administration in healthy subjects

Psychopharmacology, 2022-06, Vol.239 (6), p.1893-1905

2022

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects

British journal of clinical pharmacology, 2019-07, Vol.85 (7), p.1474-1483

2019

Link zum Volltext

Verfügbarkeit prüfen

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants

Psychopharmacology, 2022-06, Vol.239 (6), p.1933-1943

2022

Link zum Volltext

Verfügbarkeit prüfen

MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy

Progress in neuro-psychopharmacology & biological psychiatry, 2024-01, Vol.128, p.110843-110843, Article 110843

2024

Link zum Volltext

Verfügbarkeit prüfen

Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects

Psychopharmacology, 2018-05, Vol.235 (5), p.1389-1402

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of total sleep deprivation on sensorimotor gating in humans

Behavioural brain research, 2023-07, Vol.449, p.114487-114487, Article 114487

2023

Link zum Volltext

Verfügbarkeit prüfen

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

Neuropsychopharmacology (New York, N.Y.), 2023-07, Vol.48 (8), p.1175-1183

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects

European neuropsychopharmacology, 2017-03, Vol.27 (3), p.232-238

2017

Link zum Volltext

Verfügbarkeit prüfen

Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study

The Journal of steroid biochemistry and molecular biology, 2019-02, Vol.186, p.212-225

2019

Link zum Volltext

Verfügbarkeit prüfen

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals

Pharmacogenetics and genomics, 2016-08, Vol.26 (8), p.397-401

2016

Link zum Volltext

Verfügbarkeit prüfen

Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration

Biological psychiatry : cognitive neuroscience and neuroimaging, 2022-09, Vol.7 (9), p.885-894

2022

Link zum Volltext

Verfügbarkeit prüfen

No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA

European journal of clinical pharmacology, 2018-03, Vol.74 (3), p.275-283

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects

Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

Prediction of MDMA response in healthy humans: a pooled analysis of placebo-controlled studies

Oxytocin receptor gene variations and socio-emotional effects of MDMA: A pooled analysis of controlled studies in healthy subjects

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens

Correction to: Safety pharmacology of acute LSD administration in healthy subjects

No Influence of Dopamine System Gene Variations on Acute Effects of MDMA

Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects

Effects of 3,4-Methylenedioxymethamphetamine on Conditioned Fear Extinction and Retention in a Crossover Study in Healthy Subjects

In vitro and in vivo metabolism of psilocybin's active metabolite psilocin

Safety pharmacology of acute MDMA administration in healthy subjects

Safety pharmacology of acute LSD administration in healthy subjects

Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects

Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants

MDMA-assisted psychotherapy for PTSD: Growing evidence for memory effects mediating treatment efficacy

Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects

Effects of total sleep deprivation on sensorimotor gating in humans

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects

Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals

Characterizing Thalamocortical (Dys)connectivity Following D-Amphetamine, LSD, and MDMA Administration

No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA

Suchergebnisse filtern